Curanex Pharmaceuticals Inc
For the period ended Sep 30, 2025. Filed Nov 17, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 17, 2025
CURX$6.09-1.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Unaudited Financial Statements
Item 1. Financial Statements.
FINANCIAL STATEMENTS
AS OF SEPTEMBER 30, 2025 AND DECEMBER 31, 2024
AND FOR THREE AND NINE MONTHS ENDED
SEPTEMBER 30, 2025 AND 2024
INDEX TO FINANCIAL STATEMENTS
| Balance Sheets | 6 |
|---|---|
| Statements of Operations | 7 |
| Statements of Changes in Shareholders’ Equity | 8 |
| Statements of Cash Flows | 9 |
| Notes to Financial Statements | 10 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.